hexamethonium has been researched along with Salmonella Infections, Animal in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Salmonella Infections, Animal: Infections in animals with bacteria of the genus SALMONELLA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunsson, I | 1 |
1 other study available for hexamethonium and Salmonella Infections, Animal
| Article | Year |
|---|---|
Enteric nerves mediate the fluid secretory response due to Salmonella typhimurium R5 infection in the rat small intestine.
Topics: Animals; Atropine; Enteritis; Hexamethonium; Hexamethonium Compounds; Ileum; Indomethacin; Intestina | 1987 |